Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in London (Actrapid insulin+Gloucose, Actrapid insulin)

Terminated
  • Diabetes Mellitus, Type 2
  • Actrapid insulin+Gloucose
  • Actrapid insulin
  • London, United Kingdom
    Imperial College London, Charing Cross Hospital
Aug 19, 2020

Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • MEDI0382 low dose
  • +4 more
  • Birmingham, Alabama
  • +118 more
Jul 31, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Glendale, Arizona
  • +87 more
Aug 10, 2020

Diabetes, Type 2, Diabetes Trial in Worldwide (DMR Procedure (Fractyl))

Completed
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus
  • DMR Procedure (Fractyl)
  • Brussels, Belgium
  • +6 more
Jun 3, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Insulin Therapy in Type 2 Diabetes

Completed
Has Results
  • Diabetes Mellitus, Type 2
    • Little Rock, Arkansas
    • +152 more
    Feb 25, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anniston, Alabama
    • +118 more
    Feb 14, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anaheim, California
    • +118 more
    Jan 8, 2020

    Tresiba® After Switching Basal Insulin inPopulation With Type 1

    Completed
    • Diabetes Mellitus, Type 1
    • Diabetes Mellitus, Type 2
    • Insulin degludec
    • Calgary, Alberta, Canada
    • +31 more
    Dec 5, 2019

    Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Diabetic Nephropathy
    • Birmingham, Alabama
    • +592 more
    Dec 4, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Liraglutide)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Burgas, Bulgaria
    • +91 more
    Oct 2, 2019

    Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)

    Completed
    Has Results
    • Cardiovascular Disease
    • Diabetes Mellitus, Type 2
    • Mobile, Alabama
    • +300 more
    Sep 18, 2019

    Insulin Degludec inReal World Population With Type 1 and 2

    Completed
    • Diabetes
    • +2 more
    • insulin degludec
    • Århus, Denmark
    • +7 more
    Sep 30, 2019

    Diabetes, Diabetes, Type 2, Sedentary Lifestyle Trial in London (Non-Sedentary Behaviour Modelling)

    Completed
    • Diabetes
    • +2 more
    • Non-Sedentary Behaviour Modelling
    • London, Ontario, Canada
    • +1 more
    Sep 30, 2019

    Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Insulin glargine, 300 U/ml
    • +3 more
    • Birmingham, Alabama
    • +426 more
    Aug 28, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Alabaster, Alabama
    • +427 more
    Jul 3, 2019

    Diabetic Patients - Pilot Study

    Withdrawn
    • Diabetes Mellitus, Type 2
    • Cambridge, United Kingdom
    • +3 more
    Jul 8, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +252 more
    Jun 20, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anniston, Alabama
    • +85 more
    May 28, 2019

    Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Huntsville, Alabama
    • +648 more
    Mar 21, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Concord, California
    • +96 more
    Mar 6, 2019

    Diabetes, Type 2 Trial in Canada, United States (ITCA 650 20/60 mcg/day, Empagliflozin (oral), Glimepiride (oral))

    Terminated
    • Diabetes Mellitus, Type 2
    • ITCA 650 20/60 mcg/day
    • +2 more
    • Fountain Hills, Arizona
    • +100 more
    Mar 4, 2019

    Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • +2 more
    • Placebo
    • +2 more
    • Birmingham, Alabama
    • +312 more
    Nov 5, 2018

    Diabetes, Type 2 Trial in Worldwide (Insulin glargine, 300U/mL, Insulin degludec, 100 U/mL, Non-insulin anti-diabetic treatment)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Insulin glargine, 300U/mL
    • +2 more
    • Sheffield, Alabama
    • +157 more
    Aug 14, 2018

    Diabetes, Type 2 Trial in Worldwide (SRT2104, Placebo)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Byala, Bulgaria
    • +60 more
    May 2, 2018